Press, R. D., Eickelberg, G., Froman, A., Yang, F., Stentz, A., Flatley, E. M., . . . Cook, R. J. (2019). Next‐generation sequencing‐defined minimal residual disease before stem cell transplantation predicts acute myeloid leukemia relapse. American journal of hematology, 94(8), 902-912. https://doi.org/10.1002/ajh.25514
Citace podle Chicago (17th ed.)Press, Richard D., et al. "Next‐generation Sequencing‐defined Minimal Residual Disease Before Stem Cell Transplantation Predicts Acute Myeloid Leukemia Relapse." American Journal of Hematology 94, no. 8 (2019): 902-912. https://doi.org/10.1002/ajh.25514.
Citace podle MLA (9th ed.)Press, Richard D., et al. "Next‐generation Sequencing‐defined Minimal Residual Disease Before Stem Cell Transplantation Predicts Acute Myeloid Leukemia Relapse." American Journal of Hematology, vol. 94, no. 8, 2019, pp. 902-912, https://doi.org/10.1002/ajh.25514.